Riverpoint Pharmacy Recalls PAP/PHEN/PGE1 Injection Due to Sterility Concerns
First Pharma Associates dba Riverpoint Pharmacy is recalling specific lots of PAP/PHEN/PGE1 Injection because the sterility of the product cannot be assured.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric for drug recalls involving potential serious health consequences.
Plain-English summary
First Pharma Associates LLC dba Riverpoint Pharmacy, located in Spokane, Washington, is recalling specific lots of PAP/PHEN/PGE1 22 mg/0.8mg/8mcg/mL Injection, 5mL vials. The recall is being conducted because the company cannot assure the sterility of the affected product.
The affected product is prescription-only and was distributed in Idaho and Washington. The specific lot number is 06112019@32, with an expiration date of 07/27/2019.
Consumers and healthcare providers who have this specific lot of the injection should stop using it and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- PAP/PHEN/PGE1 22 mg/0.8mg/8mcg/mL Injection, 5mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252
- Category
- Drug — Injection
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 06112019@32
- Exp. 07/27/2019
Distribution
Part of a larger recall action
This product is one of 18 recalled by First Pharma Associates LLC dba Riverpoint Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · First Pharma Associates LLC dba Riverpoint Pharmacy
See all →- SevereHydroxocobalamin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-07-17
- SevereMethylcobalamin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-07-17
- HighTestosterone Cypionate Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-07-17
- SevereRiverpoint Pharmacy Recalls Chorionic Gonadotropin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-07-17
- SevereRiverpoint Pharmacy Recalls Testosterone Cyp/Estradiol Cyp Injection Due to Sterility Concerns
FDA (Drugs) · 2019-07-17
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighKey Pharmacy Recalls Compounded PGE1/PAP Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SeverePremier Pharmacy Labs Recalls Lidocaine and Phenylephrine Injection Vials
FDA (Drugs) · 2019-07-03
- SevereB&B Pharmacy Recalls PAPA/PGE1/PHENTO Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-18
- SevereFallon Wellness Pharmacy Recalls Papaverine Injection Due to Sterility Concerns
FDA (Drugs) · 2016-12-14
- HighCompounded Lidocaine-Phenylephrine Injectable Recalled Due to Sterility Assurance Issues
FDA (Drugs) · 2023-10-25
- SevereB&B Pharmacy Recalls PAPA+PGE1+PHENTO Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-18